Canada markets close in 6 hours 1 minute

Citius Pharmaceuticals, Inc. (CTXR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6985-0.0180 (-2.51%)
As of 09:57AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-09-30
2022-09-30
2021-09-30
2020-09-30
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
13,996
14,820
17,655
12,241
8,813
Selling General and Administrative
24,827
21,912
15,661
11,291
8,898
Total Operating Expenses
38,823
36,732
33,316
23,532
17,711
Operating Income or Loss
-38,823
-36,732
-33,316
-23,532
-17,711
Interest Expense
-
-
0
10.839
15.673
Total Other Income/Expenses Net
-
3,586
-
226.474
110.207
Income Before Tax
-37,604
-31,967
-33,065
-23,054
-17,548
Income Tax Expense
576
576
576
0
0
Income from Continuing Operations
-38,180
-32,543
-33,641
-23,054
-17,548
Net Income
-38,180
-32,543
-33,641
-23,054
-17,548
Net Income available to common shareholders
-39,332
-33,694
-33,641
-24,505
-17,548
Basic EPS
-0.22
-0.22
-0.23
-0.23
-0.45
Diluted EPS
-0.22
-0.22
-0.23
-0.23
-0.45
Basic Average Shares
151,295
151,295
146,082
108,599
39,165
Diluted Average Shares
151,295
151,295
146,082
108,599
39,165